Covered recipient · General Payments record
DONNA M SCHULTICE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care
General Payments · PY2021–2024
$1,625.08
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.93 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $69.53 | 3 |
| Novo Nordisk AS | $68.53 | 4 |
| PFIZER INC. | $51.96 | 3 |
| ABBVIE INC. | $51.66 | 3 |
| Neos Therapeutics, LP | $31.30 | 2 |
| DEXCOM, INC. | $24.62 | 1 |
| Lilly USA, LLC | $17.76 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.57 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.29 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108161957 | CMS |
| ABBVIE INC. | $18.83 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108161959 | CMS |
| ABBVIE INC. | $18.54 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108161961 | CMS |
| Dexcom, Inc. | $24.62 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153358357 | CMS |
| Exact Sciences Corporation | $21.08 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114523467 | CMS |
| Exact Sciences Corporation | $24.46 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114523471 | CMS |
| Exact Sciences Corporation | $23.99 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114523476 | CMS |
| Lilly USA, LLC | $17.76 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135549579 | CMS |
| Neos Therapeutics, LP | $16.36 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082663279 | CMS |
| Neos Therapeutics, LP | $14.94 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082666799 | CMS |
| Novo Nordisk Inc | $19.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100269254 | CMS |
| Novo Nordisk Inc | $16.23 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100301877 | CMS |
| Novo Nordisk Inc | $15.99 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100494003 | CMS |
| Novo Nordisk Inc | $17.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638720 | CMS |
| PFIZER INC. | $16.06 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132031183 | CMS |
| PFIZER INC. | $14.13 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576132 | CMS |
| PFIZER INC. | $21.77 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131839014 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.57 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153670182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.